Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2018
Price : $35 *
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Takeda
- 31 Aug 2018 Biomarkers information updated
- 22 Apr 2016 Status changed from active, no longer recruiting to completed.
- 25 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Oct 2015 as reported by Clinical.Trials.gov record.